INTEGRATED BIOINFORMATICS PLATFORM

Clustering Analysis

Clustering is a powerful method used to organize both metabolites and samples into meaningful groups. It reduces complexity and guides focused, hypothesis-driven research.

Clustering Analysis Overview

Shed light on the intricate relationships among samples or metabolites by revealing how groups of samples or metabolites are interrelated. Our clustering analysis tool intelligently identifies the optimal grouping parameters, making the analysis more accessible.

Clustering is a staple method in the field of data analytics and bioinformatics, used for grouping entities based on their similarities. This technique is crucial in revealing the inherent structures within data, often leading to insightful discoveries in various scientific domains. Grasping the nuances of clustering can significantly enhance your understanding of your data’s hidden patterns and relationships.

Clustering Analysis within Metabolon’s Integrated Bioinformatics Platform

In metabolomics, clustering is a powerful method used to organize both metabolites and samples into meaningful groups. It reduces complexity and guides focused, hypothesis-driven research, offering a clearer view of the metabolic landscape and its implications for health and disease.

Pathway Insights
Metabolites that are clustered together often participate in the same or related metabolic pathways. By observing which metabolites co-cluster, researchers can infer their involvement in common biochemical processes. For instance, if a group of amino acids clusters together, it might indicate their collective role in protein synthesis or degradation pathways.

Biomarker Discovery
Groups of metabolites that cluster in specific conditions might be potential biomarkers, aiding in disease understanding and treatment.

Hypothesis Generation
Clusters can prompt hypotheses about biological processes, guiding further targeted research. In addition, samples can also be clustered for further analysis.

Phenotype Characterization
Grouping related samples based on metabolic profiles can help distinguish phenotypes or conditions.

Response Patterns
Clustering samples helps identify common response patterns to treatments or environmental changes, providing insights into system dynamics.

A User-Friendly Experience

Variety of Clustering Algorithms
Interactive Visualizations
Integration with Other Analyses

Variety of Clustering Algorithms

Access a range of algorithms including K-means, hierarchical, and DBSCAN, each suited for different types of data and research questions.

Interactive Visualizations

Dynamic and interactive visualizations allow you to explore the clusters and their characteristics, thereby enhancing understanding and interpretation.

Integration with Other Analyses

Seamless integration with other tools in the platform, such as volcano analysis, allows you to explore the resulting clusters with other analytical approaches.

Clustering Features

Hierarchical Clustering (HC)

PLSDA Plot

Hierarchical clustering in our platform allows for the clustering of both metabolites and samples. Hierarchical clustering is a cluster analysis method that identifies relationships between the elements (metabolites or samples) in the clusters. This dual functionality is important for analyzing different aspects of metabolomics data. Depending on what is chosen for analysis, the heatmap displays the intensities of metabolites or samples. Clustering metabolites can reveal patterns in biochemical relationships and pathways while clustering samples can help in understanding variations across different conditions or phenotypes.

Cluster Embedding

Cluster Embedding

Embedding is the process of representing something in a computer. Cluster embedding is a technique that reduces the dimensionality of data. By converting the metabolomics data to numbers that the computer can analyze, the complexity of the data is reduced. Unlike hierarchical clustering, embedding focuses on representing the data in a way that may reveal patterns not immediately observable in the raw dataset, potentially revealing subtypes within conditions or diseases. This approach is particularly advantageous in metabolomics, where the high-dimensional nature of the data can obscure underlying patterns when viewed in its raw form.

Cluster Correlation

Cluster Correlation

The cluster correlation feature in Metabolon’s Bioinformatics Platform extends the clustering analysis by incorporating correlation metrics to evaluate the relationships between metabolites or samples. This feature is vital for identifying co-regulation and potential interactions within the metabolomics data.

Initially, the tool computes a pairwise correlation matrix, assessing the degree to which metabolites or samples vary together across different conditions. This step is foundational as it quantifies the strength and direction of the relationships. Following the correlation analysis, the Spectral bi-clustering algorithm1 is applied. This technique is designed to simultaneously cluster rows and columns, thereby identifying homogeneous blocks within the matrix—groups of metabolites or samples with similar correlation patterns.

When visualizing the results, you can interact with the correlation matrix, adjusting parameters such as the correlation coefficient threshold to refine the granularity of the bi-clusters. Visual tools include heatmaps that provide an intuitive way to interpret the correlation data. The resulting bi-clusters are also overlaid on the heatmap to easily determine which points in the correlation matrix belong to which cluster.

References

1. Kluger, Yuval, et al. “Spectral biclustering of microarray data: coclustering genes and conditions.” Genome research 13.4 (2003): 703-716.

 

Bioinformatics Platform

Demo the Bioinformatics Platform

Advanced analysis and data enrichment tools, curated pathways, statistics, and customizable visualizations all included within our Integrated Bioinformatics Platform.

great place to work logo

Demo our Bioinformatics Platform

Advanced analysis and data enrichment tools, curated pathways, statistics, and customizable visualizations all included within our Integrated Bioinformatics Platform.

By entering your email, you agree to receive a follow-up to help you complete your demo

GET STARTED

Talk with an expert

Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.

Find us on:

Talk with a Metabolomics expert

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.